Log in to save to my catalogue

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722692

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Hospitalized adults with severe Covid-19 pneumonia were randomly assigned in a 2:1 ratio to receive convalescent plasma or placebo. At 30 days, no significant difference in clinical status was noted between the two groups. Overall mortality was 11.43% with placebo and 10.96% with convalescent plasma, a difference that was not significant.

Alternative Titles

Full title

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722692

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7722692

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2031304

How to access this item